Following the September 2024 NENC Medicines Guidelines Group we now seek comments from across the NENC ICB on this new draft NENC SCG for wide guideline for Hydroxycarbamide for myeloproliferative disorders for patients within adult services which is proposed to replace the existing hydroxycarbamide SCGs that currently exist only in County Durham and North Cumbria.
This consultation closes at 5pm on Monday 14th October 2024. Visit the consultation page here.